Directors
-
Senior Vice-President, Operations & Quality, Mount Sinai Heart
Director, Interventional Cardiology, Mount Sinai Health System
President, Mount Sinai Heart Network
Anandi Lal Sharma Professor of Medicine (Cardiology)
The Mount Sinai Hospital
New York, New York
Samin K. SharmaMD, FACC, MSCAI
-
Director of the Cardiac Catheterization Laboratory
Director of Interventional Cardiology Fellowship Program
Director of Interventional Structural Heart Disease Program
Director of Process Optimization System Catheterization Laboratories
Mount Sinai Health System
New York, New York
Annapoorna S. Kini MD, MRCP, FACC
-
Director, Interventional Cardiovascular Research and Clinical Trials
Professor of Medicine (Cardiology) and Population Health Science and Policy
The Mount Sinai Hospital
New York, New York
Roxana MehranMD, FACC, MSCAI, FESC
DIRECTORS
Samin K. Sharma, MD, FACC, MSCAIAnnapoorna S. Kini, MD, MRCP, FACC
Roxana Mehran, MD, FACC, MSCAI, FESC
CO-DIRECTORS
Pedro R. Moreno, MD, FACCGeorge Dangas, MD, PhD, FACC, MSCAI
Joseph M. Sweeny, MD, FACC
Parasuram M. Krishnamoorthy, MD, FACC
Amit Hooda, MD, FACC
Gregg W. Stone, MD, FACC, MSCAI
2024 CCC Symposium Overview
The core objective of this course is to elucidate a comprehensive, multi-device approach to revascularization in patients grappling with complex coronary artery disease focusing on calcified bifurcation lesions. The utilization of physiological and anatomical imaging to guide interventions will be thoroughly deliberated and underscored on a case-by-case basis. Technical intricacies encountered during the execution of complex interventions will be vividly demonstrated through live case presentations.
Esteemed faculty members, serving as our invited experts, will spearhead the live case presentations, fostering interactive discussions centered on the treatment modalities for a spectrum of challenging scenarios of various types of calcified bifurcation lesions in patients with varying degree of left ventricular dysfunction.
Moreover, we have incorporated an interactive segment comprising focused, case-based presentations on several contentious topics, inviting active participation from both faculty and attendees.
Live cases, with a primary focus on technical nuances, will be conducted alongside an in-depth discussion of evidence-based practice guidelines governing the appropriateness of revascularization strategies. Within this dynamic live case format, contemporary themes will be explored, furnishing interventional cardiologists with cutting-edge insights essential for adept patient management amidst the ever-evolving landscape of interventional cardiology.
Throughout the symposium, we will highlight the enduring role of interventional cardiology in addressing complex calcified bifurcations lesions, leveraging the synergistic potential of multiple devices to ensure safe and efficacious outcomes over the long term.
Highlights
Advanced techniques for treating calcified bifurcation lesions, including atherectomy and intravascular lithotripsy (IVL), and optimizing device synergy
Interventional strategies for bifurcation lesions using 1 or 2-stent techniques, aided by Bifurcaid3D guidance
Comprehensive approach to interventions in unprotected left main disease, incorporating imaging guidance and potential LV assist
Utilizing Impella for left ventricular support, with insights from the Protect IV trial
Incorporating intravascular imaging (IVUS/OCT) and physiological assessments (FFR/IFR) for procedural optimization
Target Audience
- Interventional Cardiologists who manage patients with complex, challenging anatomy for revascularization
- Cardiology Fellows with an interest in Interventional Cardiology
- Nurses, Technicians, and other Allied Health Care Professionals who work in Cardiac Catheterization and Vascular Laboratories
Educational Objectives
Upon completion of this activity, participants will be empowered to:
- Discern the most suitable revascularization strategy for patients presenting with unprotected left main disease and multivessel complex bifurcation coronary artery disease (CAD).
- Evaluate and choose the optimal interventional approach for coronary bifurcation lesions and heavily calcified lesions.
- Appraise and determine the appropriateness of cases warranting the utilization of left ventricular assist devices (LVADs).
- Differentiate between cases meriting surgical intervention versus those best suited for percutaneous revascularization.
